PTGS2 and melanoma: AMPK activation has also been shown to inhibit the metastatic potential of melanoma cells through a reduction in the activity of the ERK signaling pathway and COX-2 protein levels [11] and by inducing autophagic cell death and apoptosis through AMPK/JNK signaling [51].